With respect to applications for the disability tax credit (DTC) by persons with type one diabetes which were rejected after the changes in wording to the letter to physicians in 2017 and were reviewed after the same changes in wording were reversed: (a) how many applications were reviewed; (b) how many of the applications in (a) were approved upon review; (c) how many of the applications in (a) were rejected again upon review; (d) how many of the applicants in (b) were notified of the approval; (e) how many of the applicants in (c) were notified of the rejection; (f) how many of the applicants in (c) were not notified of the rejection; (g) how many of the applicants in (c) appealed the rejection; (h) how many of the applicants in (f) were eligible to appeal the rejection; (i) how many of the applicants in (h) passed the due date for appeals without knowing about the rejection of their applications; and (j) had all applicants in (b) successfully appealed the rejection of their applications, how much would the aggregate disability tax credit claims cost on an annual basis?
In the House of Commons on January 28th, 2019. See this statement in context.